Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
11.63
-0.58 (-4.75%)
At close: Feb 21, 2025, 4:00 PM
11.75
+0.12 (1.03%)
After-hours: Feb 21, 2025, 7:54 PM EST
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $493.99 million as of February 21, 2025. Its market cap has increased by 1,194.04% in one year.
Market Cap
493.99M
Enterprise Value
493.46M
1-Year Change
1,194.04%
Ranking
Category
Stock Price
$11.63
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $493.99M, an increase of 122.13%. That is a compound annual growth rate of 25.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 518.63M | 40.67% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |